Increased MerTK expression in circulating innate immune cells of patients with septic shock

Intensive Care Medicine

Volumn 39, Issue 9, 2013, Pages 1556-1564

  Guignant, Caroline ^a,b   Venet, Fabienne ^a,b   Planel, Séverine ^a   Demaret, Julie ^a,b   Gouel Chéron, Aurélie ^a   Nougier, Christophe ^a   Friggeri, Arnaud ^b,c   Allaouchiche, Bernard ^a,b   Lepape, Alain ^b,c   Monneret, Guillaume ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Axl; Immune dysfunctions; MerTK; Septic shock; TAM receptors; Tyro 3

Indexed keywords

AXL TYROSINE KINASE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; MER TYROSINE KINASE RECEPTOR; MESSENGER RNA; PROTEIN S; TYROSINE 3 KINASE RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL STUDY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INJURY SEVERITY; INNATE IMMUNITY; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPTIC SHOCK;

AGED; FEMALE; HUMANS; INJURY SEVERITY SCORE; LEUKOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SHOCK, SEPTIC; WOUNDS AND INJURIES;

EID: 84881482018     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3006-9     Document Type: Article

References (31)

1. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
2. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, Vincent JL, Townsend S, Lemeshow S, Dellinger RP (2012) Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 12:919-924
3. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15:496-497
4. Monneret G, Venet F, Pachot A, Lepape A (2008) Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14:64-78
5. Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260-268
6. Hafizi S, Dahlback B (2006) Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 273:5231-5244
7. Benzakour O, Gely A, Lara R, Coronas V (2007) Gas-6 and protein S: vitamin K-dependent factors and ligands for the TAM tyrosine kinase receptors family. Med Sci (Paris) 23:826-833
8. Lemke G, Rothlin CV (2008) Immunobiology of the TAM receptors. Nat Rev Immunol 8:327-336
9. Lu Q, Lemke G (2001) Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293:306-311
10. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
11. Landelle C, Lepape A, Francais A, Tognet E, Thizy H, Voirin N, Timsit JF, Monneret G, Vanhems P (2008) Nosocomial infection after septic shock among intensive care unit patients. Infect Control Hosp Epidemiol 29:1054-1065
12. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175-1183
13. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35:678-686
14. Hafizi S, Dahlback B (2006) Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 17:295-304
15. Castoldi E, Hackeng TM (2008) Regulation of coagulation by protein S. Curr Opin Hematol 15:529-536
16. Rigby AC, Grant MA (2004) Protein S: a conduit between anticoagulation and inflammation. Crit Care Med 32:S336-S341
17. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G (2007) TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124-1136
18. Lee YJ, Han JY, Byun J, Park HJ, Park EM, Chong YH, Cho MS, Kang JL (2012) Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-kappaB activation and enhances inflammatory responses in lipopolysaccharide- induced acute lung injury. J Leukoc Biol 91:921-932
19. Camenisch TD, Koller BH, Earp HS, Matsushima GK (1999) A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide- induced endotoxic shock. J Immunol 162:3498-3503
20. Choi JY, Park HJ, Lee YJ, Byun J, Youn YS, Choi JH, Woo SY, Kang JL (2013) Upregulation of Mer receptor tyrosine kinase signaling attenuated LPS-induced lung inflammation. J Pharmacol Exp Ther 344(2):447-458
21. O'Neill LA (2007) TAMpering with toll-like receptor signaling. Cell 131:1039-1041
22. Borgel D, Clauser S, Bornstain C, Bieche I, Bissery A, Remones V, Fagon JY, Aiach M, Diehl JL (2006) Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 34:219-222
23. Ekman C, Linder A, Akesson P, Dahlback B (2010) Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 14:R158
24. Borgel D, Bornstain C, Reitsma PH, Lerolle N, Gandrille S, Dali-Ali F, Esmon CT, Fagon JY, Aiach M, Diehl JL (2007) A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med 176:878-885
25. Xu PB, Lou JS, Ren Y, Miao CH, Deng XM (2012) Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome. J Infect 65(5):380-391
26. Deng T, Zhang Y, Chen Q, Yan K, Han D (2012) Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. Immunology 135:40-50
27. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134
28. Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A, Timpl R, Hohenester E (2006) Structural basis for Gas6-Axl signalling. EMBO J 25:80-87
29. Brown JE, Krodel M, Pazos M, Lai C, Prieto AL (2012) Cross- phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells. PLoS One 7:e36800
30. Gouel-Cheron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G (2012) Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One 7:e33095
31. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D (2009) Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med 37:2746-2752